The goal of this study was to develop a surgical method for the creation of vocal fold injuries in mice, as a precursor to the use of genetically engineered mouse models in the study of vocal fold wound healing and scar formation.
INTRODUCTION
Vocal fold scarring often results in a severe and intractable dysphonia. 1, 2 An understanding of the wound healing process culminating in vocal fold scarring is emerging in the literature; however, the clinical management of this condition remains challenging and without consensus. The majority of work addressing scar formation and treatment in the vocal fold has relied on animal models such as dogs, pigs, rabbits, and rats. [3] [4] [5] [6] [7] [8] [9] [10] [11] Each model has distinct advantages and disadvantages in terms of vocal fold ultrastructural similarity to that of humans, the nature and extent of in vivo phonation, the availability of genome data and commercial antibodies, and animal life span, metabolism, size, ease of handling, and cost.
Tateya et al 10 pioneered the use of a rat surgical model for studying vocal fold injury and scar formation. This model capitalized on a tri-layered lamina propria, ease of handling, a relatively short life span and fast scar maturation, and a strong scientific prec-edent in other organ systems. Although this model has afforded several scientific advantages unique to rodents, the rat is a challenging model for targeted genetic manipulation using knockout, knockdown, and knock-in technology. Knockout refers to the complete inactivation of a gene of interest, knockdown refers to a targeted reduction in gene expression, and knock-in refers to the targeted insertion of a functional complementary DNA sequence at a locus of interest. A select number of knockout rat models have been generated via induced mutagenesis followed by progeny screening 12 ; however, in contrast, thousands of knockout, knockdown, and knock-in mice models have been developed for a wide array of genes by targeted vector insertion and selection in embryonic stem cells, followed by cell delivery to mouse blastocysts. 13, 14 These genetically engineered animals have proven to be powerful tools in the study of individual gene function in development and disease. injury and scar formation would facilitate the direct application of knockout, knockdown, and knock-in technology to the study of this challenging condition. The primary barrier to the use of mice for this purpose is technical. Adult mice are less than 10% of the weight of their adult rat counterparts, and the small size of the mouse larynx has previously restricted its use to nonsurgical studies. [15] [16] [17] The purpose of this study was to overcome this challenge and to establish a robust surgical approach to creation of vocal fold injuries in the mouse. This was achieved by surgical experimentation and the fabrication of several new micro-instruments. We evaluated surgical outcomes using routine histologic techniques.
The establishment of a mouse model of vocal fold

MATERIALS AND METHODS
Seven male FVB strain mice (25.7 ± 1.4 g; Harlan Sprague Dawley, Inc, Indianapolis, Indiana) were used in this study. Six animals underwent vocal fold surgery and had tissue harvested at either 1 or 7 days after surgery (3 per group). One animal was retained as a nonsurgical control.
Anesthesia. The mice were anesthetized with iso-flurane (2% to 3% delivered at 0.8 to 1.5 L/min) followed by intraperitoneal injection of ketamine hydrochloride (50 mg/kg; Ketaject, Phoenix Pharmaceutical, St Joseph, Missouri) and xylazine hydrochloride (4 mg/kg; Xyla-ject, Phoenix Pharmaceutical). Atropine sulfate (0.05 mg/kg; Phoenix Pharmaceutical) was delivered by intraperitoneal injection to reduce the production of saliva or sputum. Xylazine hydrochloride was used as a topical anesthetic in the larynx and hypopharynx.
Laryngoscope. A custom-designed laryngoscope was constructed of 1-mm-diameter stainless steel wire (Fig 1) to facilitate endoscopic visualization of the larynx. The anesthetized animals were placed in a supine position (Fig 2A) , and the laryngoscope was positioned to provide an endoscopic surgical approach (Fig 2B) .
Endoscope and Monitoring System. Surgical images were monitored with a 1.9-mm-diameter 25° endoscope (Richard Wolf, Vernon Hills, Illinois), a charge-coupled device (CCD) unit (596T, Stryker, San Jose, California), a light source (Q-5000, Stryker), a monitor (PVN-1343MD, Sony, Tokyo, Japan), and a digital hard disk video recorder (GZ-MG555U, Victor Company of Japan, Kanagawa, Japan; Fig 3) .
Surgical Instrumentation and Procedures. Three custom surgical instruments (needle, fork, and hook) were fabricated from commercial materials and used to induce vocal fold injuries. The needle instrument was based on a modified 25-gauge spinal needle (Sherwood Medical, St Louis, Missouri). This needle contains a 0.2-mm-diameter thin inner wire, which was advanced 3 mm from the needle tip and fixed with solder. The wire tip was then bent approximately 15° to allow sufficient operating space in the laryngeal lumen during use of the endoscope described above ( Fig 4A) .
The fork instrument was fabricated from a 0.25-C A B mm-diameter micro-fork (Electron Microscopy Sciences, Hatfield, Pennsylvania). The micro-fork tip was cut, inserted, and soldered to the tip of a 20gauge spinal needle (Becton Dickinson, Franklin Lakes, New Jersey; Fig 4B) .
The hook instrument was fabricated from 0.3mm-diameter stainless steel wire, which was shaped and then soldered to a larger-diameter stainless steel handle ( Fig 4C) .
Unilateral vocal fold injuries were created as follows. The needle was first inserted through the lateral aspect of the superior surface of the vocal fold ( Fig 5A) and then retracted in the medial direction to separate the mucosa from the underlying thyroarytenoid (TA) muscle ( Fig 5B) . Care was taken to minimize disturbance of the TA muscle. Next, the fork was used to straddle the newly created mucosal bridge, and then it was rotated to strip the mucosa from its remaining TA muscle attachments ( Fig 5C) . Finally, the hook was used to expose any residual mucosal flaps and evaluate the degree of tissue injury. Surgery was finished once complete exposure of the TA muscle was obtained.
Tissue Harvest and Histologic Preparation. The mice were euthanized by carbon dioxide asphyxiation (3 to 4 L/min). The larynx was harvested en bloc under an operating microscope ( Fig 6) and placed in phosphate-buffered saline solution (PBS) containing 25% sucrose for 8 hours at 4°C. Next, the larynx was placed in a cryomold and embedded in optimal cutting temperature compound (Tissue-Tek, Sakura Finetechnical, Tokyo). The samples were frozen in acetone and dry ice.
Serial 7-μm axial cryosections were prepared with a cryostat (CM-1850, Leica, Wetzlar, Germany). Routine hematoxylin and eosin (H & E) staining was performed to confirm the vocal fold injury site. In addition, immunohistochemistry (IHC) staining for the fibrous proteins collagen type I and elastin was performed for the control larynx. The IHC was not performed for the injured samples, as meaningful extracellular matrix (ECM) remodeling was not anticipated during the first 7 days after injury.
Fluorescent IHC was performed by the following standard protocol. The samples were fixed with 4% paraformaldehyde for 10 minutes at room temperature (RT) and treated with 0.5% Triton X-100 (Sigma-Aldrich, St Louis) in blocking solution (1:10; BUF029, Serotec, Raleigh, North Carolina) for 15 minutes at RT. Primary antibodies were applied for 1 hour at RT. Secondary antibodies were also applied for 1 hour at RT. Then 4',6-diamidino-2-phenylindole dihydrochloride (2 mg/mL DAPI; MP Biomedicals, Santa Ana, California) was applied for 20 minutes as a nuclear stain.
The primary antibodies used in this study were rabbit anti-collagen type I (1:50; ab34710, Abcam, Cambridge, Massachusetts) and goat anti-elastin 
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A B samples were exposed to the secondary antibody in the absence of the primary antibody, revealed no immunostain.
The stained images were visualized and captured with a microscope with both conventional bright field and fluorescent capabilities (E600, Nikon, To kyo) con nected to a digital microscopy camera (DP70, Olympus, Tokyo).
RESULTS
Vocal fold visualization was successfully achieved in all 7 mice. Figure 7 contains 2 representative images from an intact mouse larynx.
Unilateral vocal fold injuries were successfully created in the 6 mice that underwent surgery. One mouse developed postoperative stridor secondary to laryngeal edema that was successfully managed by delivery of 100% oxygen at 3 L/min for approximately 30 minutes. Intubation was not attempted because of the risk of exacerbating the laryngeal edema.
Representative IHC data showing collagen type I and elastin distribution in the control larynx are presented in Figs 8 and 9 . Collagen type I was diffusely present throughout the entire lamina propria, and was densely concentrated in the basement membrane region. Elastin immunostaining demonstrated sparse cellular and ECM distribution throughout the lamina propria, with greater abundance in the epithelium. The anti-elastin antibody used in this study binds to both the precursor tropoelastin and mature elastin. Figure 10A illustrates an H & E-stained section from the control mouse larynx. The lamina propria was characterized by a relatively simple structure. Figure 10B illustrates an H & E-stained section from a larynx harvested 1 day after surgery. The operated vocal fold was characterized by obliteration of the epithelial and subepithelial structures, a fibrin clot, and lymphocyte infiltration. Sections from the other 2 larynges harvested 1 day after surgery also demonstrated these features.
Seven days after surgery, the injured vocal folds from all 3 animals demonstrated complete reepithelialization. Two samples were characterized by a relatively sparse lamina propria structure in the injured vocal fold compared with the control vocal fold ( Fig  10C) ; the third sample showed no difference between the injured and control vocal folds.
DISCUSSION
The goal of this study was to develop a surgical method for the creation of vocal fold injuries in mice, as a precursor to the use of genetically engineered mouse models in the study of vocal fold wound healing and scar formation. A laryngoscope and 3 surgical instruments were designed and fabricated for this purpose. The needle instrument was designed to make a superior vocal fold incision without interference from the epiglottis or the working endoscope. The fork instrument was designed to facilitate the removal of vocal fold mucosa giv-en limited operating space in the laryngeal lumen. The hook instrument was designed to evaluate the extent of vocal fold injury after use of the needle and fork. Operating with the mouse in a supine position enabled us to manipulate all instruments with maximum accuracy and control. A lightweight CCD camera module and a 25° endoscope were also critical to successful vocal fold visualization and surgical manipulation.
We utilized fluorescent IHC to evaluate collagen type I and elastin distribution in the uninjured mouse vocal fold, and used routine H & E staining to evaluate the vocal fold injury site and reepithelialization in each experimental animal. Our initial experience processing laryngeal samples without sucrose treatment resulted in significant image artifact due to ice crystal formation in the TA muscle (data not shown). This artifact was not present in samples treated with 25% sucrose for 8 hours. Our evaluation of the uninjured control mouse vocal fold revealed a relatively simple lamina propria structure with diffuse collagen type I and tropoelastin and elastin distribution. Both fibrous proteins demonstrated relatively even distribution as a function of lamina propria depth, with no apparent layer structure as has been reported in humans and other animal models. 18 This finding is consistent with that of Abdelkafy et al, 15 strain mice, and identified decreased glycosaminoglycan abundance and increased collagen abundance in old compared with young mice. As noted earlier, we did not evaluate alteration in fibrous protein abundance or organization in the injured vocal folds in this study, as meaningful ECM remodeling was not anticipated during the first 7 days after injury. Additional work is required to characterize this remodeling phase and eventual scar formation in the mouse model.
The data presented here demonstrate that the surgical removal of vocal fold mucosa is possible in mice. The 3 larynges harvested 1 day after surgery showed obliteration of the epithelium and lamina propria, deposition of a fibrin clot, and infiltration of inflammatory cells. We observed reepithelialization of all injured vocal folds by 7 days after surgery, which is slightly less than the 7 to 14 days reported by Tateya et al 19 in a Sprague Dawley rat model. Two larynges out of 3 were characterized by relatively sparse lamina propria on the injured vocal fold side at 7 days. This finding could represent residual edema, immature cross-linking between regenerating fibers, or even an artifact in cryosectioning.
CONCLUSIONS
These results demonstrate the feasibility of creating reproducible vocal fold injuries via an endoscopic approach in mice. The availability of gene knockout, knockdown, and knock-in models makes the mouse an attractive candidate for studying individual targeted genes as they relate to vocal fold structure and function. The observation that the mouse lamina propria has a relatively simple histologic structure indicates that additional characterization should be performed and caution used when translating findings between this and other model systems.
